Creating a special gel to help muscle stem cells grow and stay healthy
Engineered Asymmetric Hydrogel for Muscle Stem Cell Polarity and Fate Specification
This study is looking at ways to help muscle stem cells grow better so they can be used in treatments for muscle injuries and diseases, by creating a special gel that mimics their natural environment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11012398 on NIH RePORTER |
What this research studies
This research focuses on improving the growth and effectiveness of muscle stem cells (MuSCs) for potential therapies related to muscle injuries and diseases. The team aims to develop an engineered hydrogel that mimics the natural environment of these cells, allowing them to maintain their 'stemness' and division capabilities over time. By using this innovative approach, the researchers hope to enhance the ability to culture MuSCs outside the body, which is crucial for future treatments. The study will explore how mechanical and biochemical factors can influence the behavior of these cells in a controlled setting.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with muscle injuries or degenerative muscle diseases who may benefit from advanced stem cell therapies.
Not a fit: Patients with non-muscle related conditions or those who do not have access to stem cell therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for muscle-related conditions by improving the viability and functionality of muscle stem cells used in therapies.
How similar studies have performed: While the approach of using engineered hydrogels for stem cell culture is gaining traction, this specific method targeting muscle stem cells is relatively novel and has not been extensively tested.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Han, Woojin — Icahn School of Medicine at Mount Sinai
- Study coordinator: Han, Woojin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.